Skip to main content
. 2023 Oct 10;21:710. doi: 10.1186/s12967-023-04409-8

Table 2.

CD22 expression levels and clinical parameters in ESCC tissues (n = 87)

Clinical parameters CD22
Total Expression P-value
n % Negative Positive
n % n %
Total number 87 100.00 17 19.54 70 80.46
Sex 1.000
 Female 20 22.99 4 20.00 16 80.00
 Male 67 77.01 13 19.40 54 80.60
Age 0.592
 ≤ 59 41 47.13 9 21.95 32 78.05
 ≥ 60 46 52.87 8 17.39 38 82.61
Depth of tumor invasion 0.137
 pT1–pT2 14 16.09 5 35.71 9 64.29
 pT3–pT4 73 83.91 12 16.44 61 83.56
Lymph node metastasis 0.008
 Negative 32 36.78 11 34.38 21 65.63
 Positive 55 63.22 6 10.91 49 89.09
Clinical stage 0.546
 I–II 24 27.59 6 25.00 18 75.00
 III–IV 63 72.41 11 17.46 52 82.54